Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-17-050305

Chief Financial Officer bought 2,000 shares at $2.64 ($5,285)

From the SEC's structured data for this filing

Trades in this filing

SKIBSTED RUSSELL · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-08-23 Purchase : show line 1 in the form +2,000 $2.64 $5,285 2,000 D
Open-market purchases · 2,000 sh · avg $2.64 · $5,285
Loading xslF345X03/doc4.xml…